Menu
About
Overview
History
Values
Management
Board of Directors
Diversity & Inclusion
Social Community Guidelines
Pipeline
Overview
Voxelotor for Sickle Cell Disease
Patients
GBT's Commitment
About Sickle Cell Disease
Investigational Medicines
Stay Informed
Investors
Investor Overview
Press Releases
Events & Presentations
Stock Information
Analyst Coverage
SEC Filings
Corporate Governance
Investor FAQs
E-mail Alerts
IR Contact
Media
Careers
Contact
Investors
SEC Filings
Form 10-Q
GLOBAL BLOOD THERAPEUTICS, INC. filed this
Form 10-Q
on 11/06/2018
Document Outline
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT
(
What's this?
)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
(
What's this?
)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
(
What's this?
)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
(
What's this?
)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
(
What's this?
)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
(
What's this?
)
XBRL Viewer
